Literature DB >> 16982523

Effects of Fusarium toxin-contaminated wheat and feed intake level on the biotransformation and carry-over of deoxynivalenol in dairy cows.

K Seeling1, S Dänicke, H Valenta, H P Van Egmond, R C Schothorst, A A Jekel, P Lebzien, M Schollenberger, E Razzazi-Fazeli, G Flachowsky.   

Abstract

An experiment was carried out to examine the effects of feeding Fusarium toxin-contaminated wheat (8.21 mg deoxynivalenol (DON) and 0.09 mg zearalenone (ZON) per kg dry matter) at different feed intake levels on the biotransformation and carry-over of DON in dairy cows. For this purpose, 14 ruminal and duodenal fistulated dairy cows were fed a diet containing 60% concentrate with a wheat portion of 55% (Fusarium toxin-contaminated wheat (mycotoxin period) or control wheat (control period)) and the ration was completed with maize- and grass silage (50 : 50) on a dry matter basis. Daily DON intakes ranged from 16.6 to 75.6 mg in the mycotoxin period at dry matter intakes of 5.6-20.5 kg. DON was almost completely biotransformed to de-epoxy DON (94-99%) independent of the DON/feed intake, and the flow of DON and de-epoxy DON at the duodenum related to DON intake ranged from 12 to 77% when the Fusarium toxin-contaminated wheat was fed. In the serum samples, de-epoxy DON was detected in the range of 4-28 ng ml-1 in the mycotoxin period, while concentrations of DON were all below the detection limit. The daily excretion of DON and de-epoxy DON in the milk of cows fed the contaminated wheat varied between 1 and 10 microg and between 14 and 104 microg, respectively. The total carry-over rates as the ratio between the daily excretion of DON and de-epoxy DON into milk and DON intake were in the ranges of 0.0001-0.0002 and 0.0004-0.0024, respectively. Total carry-over rates of DON as DON and de-epoxy DON into the milk increased significantly with increasing milk yield. In the urine samples, de-epoxy DON was the predominant substance as compared with DON with a portion of the total DON plus de-epoxy DON concentration to 96% when the Fusarium toxin-contaminated wheat was fed, whereas the total residues of DON plus de-epoxy DON in faeces ranged between 2 and 18% of DON intake in the mycotoxin period. The degree of glucuronidation of de-epoxy DON was found to be approximately 100% in serum. From 33 to 80% of DON and from 73 to 92% of de-epoxy DON, and from 21 to 92% of DON and from 86 to 100% of de-epoxy DON were glucuronidated in the milk and urine, respectively. It is concluded that DON is very rapidly biotransformed to de-epoxy DON in the rumen and only negligible amounts of DON and de-epoxy DON were transmitted into the milk within the range of 5.6-20.5 kg day-1 dry matter intake and milk yields (fat corrected milk) between 10 and 42 kg day-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982523     DOI: 10.1080/02652030600723245

Source DB:  PubMed          Journal:  Food Addit Contam        ISSN: 0265-203X


  16 in total

1.  Modified use of a commercial ELISA kit for deoxynivalenol determination in rice and corn silage.

Authors:  Hisaaki Hiraoka; Katsumi Yamamoto; Yukiko Mori; Naoki Asao; Rie Fukunaka; Kenzaburo Deguchi; Kenzi Iida; Shigeru Miyazaki; Tetsuhisa Goto
Journal:  Mycotoxin Res       Date:  2012-12-30       Impact factor: 3.833

2.  Fusarium toxin-contaminated maize in diets of growing bulls: effects on performance, slaughtering characteristics, and transfer into physiological liquids.

Authors:  Janine Winkler; Jens Gödde; Ulrich Meyer; Jana Frahm; Heiner Westendarp; Sven Dänicke
Journal:  Mycotoxin Res       Date:  2016-04-16       Impact factor: 3.833

3.  Effects of deoxynivalenol in naturally contaminated wheat on feed intake and health status of horses.

Authors:  Anna-Katharina Schulz; Susanne Kersten; Sven Dänicke; Manfred Coenen; Ingrid Vervuert
Journal:  Mycotoxin Res       Date:  2015-09-30       Impact factor: 3.833

4.  Effects of the thermal environment on metabolism of deoxynivalenol and thermoregulatory response of sheep fed on corn silage grown at enriched atmospheric carbon dioxide and drought.

Authors:  Malte Lohölter; Ulrich Meyer; Susanne Döll; Remy Manderscheid; Hans-Joachim Weigel; Martin Erbs; Martin Höltershinken; Gerhard Flachowsky; Sven Dänicke
Journal:  Mycotoxin Res       Date:  2012-09-02       Impact factor: 3.833

5.  Sample clean-up methods, immunoaffinity chromatography and solid phase extraction, for determination of deoxynivalenol and deepoxy deoxynivalenol in swine serum.

Authors:  Jianwei He; Xiu-Zhen Li; Ting Zhou
Journal:  Mycotoxin Res       Date:  2009-05-06       Impact factor: 3.833

6.  Effects of deoxynivalenol (DON) and related compounds on bovine peripheral blood mononuclear cells (PBMC) in vitro and in vivo.

Authors:  Sven Daenicke; Christina Keese; Tanja Goyarts; Susanne Döll
Journal:  Mycotoxin Res       Date:  2010-12-07       Impact factor: 3.833

7.  Deoxynivalenol in the gastrointestinal tract of immature gilts under per os toxin application.

Authors:  Agnieszka Waśkiewicz; Monika Beszterda; Marian Kostecki; Łukasz Zielonka; Piotr Goliński; Maciej Gajęcki
Journal:  Toxins (Basel)       Date:  2014-03-05       Impact factor: 4.546

8.  Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats.

Authors:  Veronika Nagl; Heidi Schwartz; Rudolf Krska; Wulf-Dieter Moll; Siegfried Knasmüller; Mathias Ritzmann; Gerhard Adam; Franz Berthiller
Journal:  Toxicol Lett       Date:  2012-08-04       Impact factor: 4.372

9.  Metabolism of deoxynivalenol and deepoxy-deoxynivalenol in broiler chickens, pullets, roosters and turkeys.

Authors:  Heidi E Schwartz-Zimmermann; Philipp Fruhmann; Sven Dänicke; Gerlinde Wiesenberger; Sylvia Caha; Julia Weber; Franz Berthiller
Journal:  Toxins (Basel)       Date:  2015-11-12       Impact factor: 4.546

10.  Bovine Peripheral Blood Mononuclear Cells Are More Sensitive to Deoxynivalenol Than Those Derived from Poultry and Swine.

Authors:  Barbara Novak; Eleni Vatzia; Alexandra Springler; Alix Pierron; Wilhelm Gerner; Nicole Reisinger; Sabine Hessenberger; Gerd Schatzmayr; Elisabeth Mayer
Journal:  Toxins (Basel)       Date:  2018-04-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.